Tofacitinib for refractory chilblain lupus erythematosus

Int J Dermatol. 2022 Apr;61(4):e156-e157. doi: 10.1111/ijd.15625. Epub 2021 Jun 1.
No abstract available

Publication types

  • Letter

MeSH terms

  • Chilblains* / diagnosis
  • Chilblains* / drug therapy
  • Humans
  • Lupus Erythematosus, Cutaneous* / diagnosis
  • Lupus Erythematosus, Cutaneous* / drug therapy
  • Lupus Erythematosus, Systemic*
  • Piperidines
  • Pyrimidines / therapeutic use

Substances

  • Piperidines
  • Pyrimidines
  • tofacitinib

Supplementary concepts

  • Chilblain lupus 1